Novacyt (NCYT) EUR0.0667 (CDI)
Share news, reports & tips
7 October 2019 15:35
(Sharecast News) - Clinical diagnostics specialist Novacyt announced the successful development of a new molecular diagnostic multiplex test for respiratory infections on Monday, which it said was ready for...
30 July 2019 15:28
(Sharecast News) - Clinical diagnostics company Novacyt updated the market on its trading for the six months ended 30 June on Tuesday, reporting that its unaudited revenues in the first half were €7.2m.
26 February 2019 15:47
(Sharecast News) - Clinical diagnostics specialist Novacyt updated the market on its current position and funding plans on Tuesday, confirming that 2019 trading had started positively and was in line with...
21 December 2018 14:31
(Sharecast News) - Clinical diagnostics specialist Novacyt announced the launch of new CE-marked approved molecular products, the 'genesig' Real-Time PCR BK virus (BKV) kit and the...
2 August 2018 11:58
(Sharecast News) - Novacyt on Thursday confirmed that it will carry out a strategic review after reporting that full-year group revenue will be lower than previously expected due to losses in its Novaprep...
28 June 2018 09:17
(Sharecast News) - In-vitro diagnostics firm Omega Diagnostics on Thursday struck a deal for the disposal of its infectious disease business, ID Assets, to clinical diagnostics specialist Novacyt for up to...
2 November 2017 10:35
(ShareCast News) - International specialist in clinical diagnostics Novacyt today announced the full recovery and settlement of the 40 pending convertible bonds under the Yorkville facility agreement, with...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2019. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.